Daniel J. Mccarthy

Internal Medicine
790 Boston Rd Ste 320320
Billerica, MA 01821

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial.

Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial.

Journal: The Lancet. Haematology
Published: February 12, 2020
Showing 1-1 of 1

Last Updated: 09/26/2026